Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1998Movement Disorders

Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAmos D. KorczynTel Aviv UniversityDBDavid J. BrooksBoston UniversityEBEhrout R. BruntUniversity of Groningen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Korczyn et al. (1998) studied this question.

synapsesocial.com/papers/6a6e028ee5469ee92bdfe1dfhttps://doi.org/10.1002/mds.870130112
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lisuride, a dopamine agonist in the treatment of early Parkinson's disease1989 · 130 citations
  2. 2Fortnightly Review: Drug treatment of Parkinson's disease1995 · 139 citations
  3. 3Long-term treatment of Parkinson's disease with bromocriptine.1979 · 78 citations
  4. 4A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine D2‐receptor agonist.1989 · 21 citations
  5. 5The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.1994 · 155 citations